BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1679 related articles for article (PubMed ID: 17257042)

  • 1. Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: a new strategy that might lead to improved activity.
    Bratsos I; Serli B; Zangrando E; Katsaros N; Alessio E
    Inorg Chem; 2007 Feb; 46(3):975-92. PubMed ID: 17257042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Half-sandwich RuII-[9]aneS3 complexes with dicarboxylate ligands: synthesis, characterization and chemical behavior.
    Bratsos I; Birarda G; Jedner S; Zangrando E; Alessio E
    Dalton Trans; 2007 Sep; (36):4048-58. PubMed ID: 17828366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unprecedented bridging coordination mode of 1,1-cyclobutane dicarboxylate (mu-cbdc-O,O') stabilized by intramolecular hydrogen bonds in ruthenium(II) complexes.
    Bratsos I; Zangrando E; Serli B; Katsaros N; Alessio E
    Dalton Trans; 2005 Dec; (24):3881-5. PubMed ID: 16311642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the anionic ligands on the anticancer activity of Ru(II)-dmso complexes: Kinetics of aquation and in vitro cytotoxicity of new dicarboxylate compounds in comparison with their chloride precursors.
    Bratsos I; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E
    J Inorg Biochem; 2008 Apr; 102(4):606-17. PubMed ID: 18063052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activity.
    Bratsos I; Simonin C; Zangrando E; Gianferrara T; Bergamo A; Alessio E
    Dalton Trans; 2011 Oct; 40(37):9533-43. PubMed ID: 21853191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isomeric [RuCl2(dmso)2(indazole)2] complexes: ruthenium(II)-mediated coupling reaction of acetonitrile with 1H-indazole.
    Reisner E; Arion VB; Rufińska A; Chiorescu I; Schmid WF; Keppler BK
    Dalton Trans; 2005 Jul; (14):2355-64. PubMed ID: 15995743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.
    Egger A; Arion VB; Reisner E; Cebrián-Losantos B; Shova S; Trettenhahn G; Keppler BK
    Inorg Chem; 2005 Jan; 44(1):122-32. PubMed ID: 15627368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, structure, and spectroscopic, photochemical, redox, and catalytic properties of ruthenium(II) isomeric complexes containing dimethyl sulfoxide, chloro, and the dinucleating bis(2-pyridyl)pyrazole ligands.
    Sens C; Rodríguez M; Romero I; Llobet A; Parella T; Sullivan BP; Benet-Buchholz J
    Inorg Chem; 2003 Mar; 42(6):2040-8. PubMed ID: 12639139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New cationic and neutral Ru(II)- and Os(II)-dmso carbonyl compounds.
    Bratsos I; Calmo S; Zangrando E; Balducci G; Alessio E
    Inorg Chem; 2013 Oct; 52(20):12120-30. PubMed ID: 24090044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A straightforward and generalizable synthetic methodology for the synthesis of ruthenium(II) complexes with thioether ligands from either Ru(III) or Ru(0) precursors.
    Maiti BK; Görls H; Klobes O; Imhof W
    Dalton Trans; 2010 Jun; 39(24):5713-20. PubMed ID: 20495720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-(2-Picolyl)-substituted 1,2,3-triazole as novel chelating ligand for the preparation of ruthenium complexes with potential anticancer activity.
    Bratsos I; Urankar D; Zangrando E; Genova-Kalou P; Košmrlj J; Alessio E; Turel I
    Dalton Trans; 2011 May; 40(19):5188-99. PubMed ID: 21465046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and dynamics of methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside complexes with PtCl(2) and PdCl(2), by (1)H, (2)H, (13)C, (15)N and (195)Pt NMR spectroscopy in DMSO, CD(3)CN and H(2)O.
    Bednarek E; Sitkowski J; Kawecki R; Kozerski L; Bocian W; Pazderski L; Priebe W
    Dalton Trans; 2008 Aug; (31):4129-37. PubMed ID: 18688431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
    Reisner E; Arion VB; Guedes da Silva MF; Lichtenecker R; Eichinger A; Keppler BK; Kukushkin VY; Pombeiro AJ
    Inorg Chem; 2004 Nov; 43(22):7083-93. PubMed ID: 15500346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
    Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
    J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, structure and spectral and redox properties of new mixed ligand monomeric and dimeric Ru(II) complexes: predominant formation of the "cis-alpha" diastereoisomer and unusual 3MC emission by dimeric complexes.
    Murali M; Palaniandavar M
    Dalton Trans; 2006 Feb; (5):730-43. PubMed ID: 16429178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic insights into the chemistry of RuII complexes containing Cl and DMSO ligands.
    Mola J; Romero I; Rodríguez M; Bozoglian F; Poater A; Solà M; Parella T; Benet-Buchholz J; Fontrodona X; Llobet A
    Inorg Chem; 2007 Dec; 46(25):10707-16. PubMed ID: 18001116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity.
    Bratsos I; Jedner S; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E
    J Inorg Biochem; 2008; 102(5-6):1120-33. PubMed ID: 18279961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. fac-[Re(CO)3(dmso-O)3](CF3SO3): a new versatile and efficient Re(I) precursor for the preparation of mono and polynuclear compounds containing fac-[Re(CO)3]+ fragments.
    Casanova M; Zangrando E; Munini F; Iengo E; Alessio E
    Dalton Trans; 2006 Nov; (42):5033-45. PubMed ID: 17060989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
    Cini R; Tamasi G; Defazio S; Corsini M; Zanello P; Messori L; Marcon G; Piccioli F; Orioli P
    Inorg Chem; 2003 Dec; 42(24):8038-52. PubMed ID: 14632524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure of cycloruthenated carbonyl complexes and their emission, redox and biological properties.
    Naresh Kumar K; Ramesh R; Liu Y
    J Inorg Biochem; 2006 Jan; 100(1):18-26. PubMed ID: 16310253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.